TAFINLAR DABRAFENIB 50 AND 75 mg

DESCRIPTION

Tafinlar is a prescribed medicine. Tafinlar interferes with the growth and spread of cancer cells in the body and is also used to treat certain types of cancer in people who have a ‘BRAF’ gene mutation . It is also used to treat skin cancer (melanoma) , non-small cell lung cancer and thyroid cancer. To buy Tafinlar or to know its price contact 3S Corporation.
Manufacturer :- Novartis Pharmaceuticals Corporation.

ADDITIONAL INFORMATION

Strengths available :- 50 mg and 75 mg
Form :-  Capsules
Storage :-  Store at 25 ° C 
Is the medicine FDA approved :- US FDA Approved
Date of approval :- 29 May , 2013
Dosage :- The recommended dosage regimen of TAFINLAR is 150 mg orally taken twice daily, approximately 12 hours apart as a single agent or with trametinib. Continue treatment until disease progression or unacceptable toxicity occurs.Take TAFINLAR at least 1 hour before or 2 hours after a meal. Do not take a missed dose of TAFINLAR within 6 hours of the next dose of TAFINLAR. Do not open, crush, or break TAFINLAR capsules.

SIDE EFFECTS

 Common side effects of Tafinlar include: squamous cell carcinoma, fever, and hyperglycemia. Other side effects include: keratoacanthom

PACK SIZE

Pack of 120 capsules

Reviews

There are no reviews yet.

Be the first to review “TAFINLAR DABRAFENIB 50 AND 75 mg”

Your email address will not be published. Required fields are marked *